Indications for: REVIA

Adjunct in treatment of alcohol or narcotic dependence.

Adult Dosage:

Confirm 7–10 day opioid-free period, if questionable do Narcan challenge test (see literature). ≥18yrs: Alcoholism: 50mg daily. Narcotic dependence: Initially 25mg, if no withdrawal symptoms increase to 50mg daily; alternative dosing schedules: see literature.

Children Dosage:

<18yrs: not recommended.

REVIA Contraindications:

Concomitant opioids, current opioid dependence, or acute opioid withdrawal. Failed Narcan challenge test or (+) urine screen for opioids. Acute hepatitis. Liver failure.

REVIA Warnings/Precautions:

Liver disease. Monitor liver function. Warn patients of danger of attempting to overcome opiate blockade. Severe renal dysfunction. Possible acute abstinence syndrome. Depression. Suicidal ideation. Pregnancy (Cat.C). Nursing mothers.

REVIA Classification:

Opioid antagonist.

REVIA Interactions:

Thioridazine increases sedation. Antagonizes opioids (eg, antitussives, antidiarrheals, analgesics). Disulfiram.

Adverse Reactions:

Hepatotoxicity, withdrawal reactions; others, see literature.

How Supplied:

Tabs—30, 100

Pricing for REVIA

50mg tablet (Qty: 30)
Appx. price $24